LPC

Lion Point Capital Portfolio holdings

AUM $14.7M
1-Year Est. Return 16.78%
This Quarter Est. Return
1 Year Est. Return
+16.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$15.7M
AUM Growth
-$3.42M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
21
New
Increased
Reduced
Closed

Top Buys

1
+$492K
2
+$272K
3
+$222K
4
HUMA icon
Humacyte
HUMA
+$142K

Top Sells

1
+$494K
2
+$473K
3
+$382K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INSM icon
1
Insmed
INSM
$35B
$2.33M 14.84%
30,500
-6,200
ARDX icon
2
Ardelyx
ARDX
$1.21B
$1.65M 10.51%
335,400
MLYS icon
3
Mineralys Therapeutics
MLYS
$3.38B
$1.25M 8%
79,000
FENC icon
4
Fennec Pharmaceuticals
FENC
$229M
$1.19M 7.6%
195,700
KNSA icon
5
Kiniksa Pharmaceuticals
KNSA
$2.86B
$1.02M 6.5%
45,900
BBIO icon
6
BridgeBio Pharma
BBIO
$10.5B
$899K 5.73%
26,000
-14,300
BNTC icon
7
Benitec Biopharma
BNTC
$411M
$807K 5.15%
62,000
GERN icon
8
Geron
GERN
$766M
$795K 5.07%
500,000
AVDL
9
Avadel Pharmaceuticals
AVDL
$1.48B
$773K 4.93%
98,700
+34,700
ARQT icon
10
Arcutis Biotherapeutics
ARQT
$2.5B
$724K 4.62%
46,300
SNDX icon
11
Syndax Pharmaceuticals
SNDX
$1.23B
$676K 4.31%
55,000
JSPR icon
12
Jasper Therapeutics
JSPR
$68.4M
$630K 4.02%
146,500
+114,500
BHVN icon
13
Biohaven
BHVN
$1.69B
$546K 3.48%
22,700
IRON icon
14
Disc Medicine
IRON
$3.13B
$526K 3.36%
10,600
MIST icon
15
Milestone Pharmaceuticals
MIST
$165M
$439K 2.8%
548,806
-477,000
RGNX icon
16
Regenxbio
RGNX
$593M
$413K 2.63%
57,750
BLUE
17
DELISTED
bluebird bio
BLUE
$385K 2.46%
78,912
MCRB icon
18
Seres Therapeutics
MCRB
$166M
$239K 1.52%
17,038
MRSN icon
19
Mersana Therapeutics
MRSN
$49.3M
$222K 1.41%
+25,760
HUMA icon
20
Humacyte
HUMA
$322M
$142K 0.91%
+83,500
SPRB
21
Spruce Biosciences, Inc. Common Stock
SPRB
$88.9M
$21.8K 0.14%
75,000